Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Ferric Carboxymaltose in Pediatric IDA
NCT02410213Phase 2Completed
- Sponsor
- American Regent, Inc.
- Start
- Feb 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by American Regent, Inc.. Started Feb 2015; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02410213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02410213.